JAC Advance Access originally published online on November 6, 2006
Journal of Antimicrobial Chemotherapy 2007 59(1):106-109; doi:10.1093/jac/dkl435
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England
1 Centre for Infections, Health Protection Agency London, UK 2 Department of Clinical Microbiology, Royal Cornwall Hospital Truro, UK
Received 9 August 2006; returned 25 September 2006; revised 2 October 2006; accepted 3 October 2006
*Correspondence address. Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London NW9 5EQ, UK. Tel: +44-20-8327-7255; Fax +44-20-8327-6264; E-mail: neil.woodford{at}hpa.org.uk
Objectives: To study the clonality of gentamicin-resistant, extended-spectrum ß-lactamase (ESBL)-negative and ESBL-producing Escherichia coli isolated from community-onset urinary tract infections (UTIs) in Cornwall.
Methods: Isolates were identified by API, susceptibilities were determined by local disc testing, and MICs were determined at the reference laboratory, both interpreted using BSAC guidelines. blaCTX-M genes were sought by PCR, and isolates were compared by PFGE.
Results: In the years 2004 and 2005, 69 E. coli were submitted by Truro (Cornwall) laboratory for reference laboratory testing: these included 14 gentamicin-resistant, ESBL-negative isolates; 45 with group 1 CTX-M enzymes; seven with group 9 CTX-M enzymes; and three with non-CTX-M ESBLs. By PFGE, nine gentamicin-resistant, ESBL-negative E. coli were distinct (<85% similarity) from all the ESBL producers, but three were related to producers of group 1 CTX-M enzymes, and two isolates were related to a non-CTX-M ESBL producer. An outbreak strain was identified, represented by 11 gentamicin-resistant and one gentamicin-susceptible isolates, all with group 1 CTX-M enzymes, and two gentamicin-resistant, ESBL-negative isolates. This was distinct by PFGE from nationally distributed CTX-M-producing strains. Five of nine patients infected with this strain had been on the same ward in a local hospital; four presented with community-onset UTIs; one inpatient developed a hospital-acquired bacteraemia. Of the other four patients presenting with community-onset UTIs, three were admitted to different hospitals and the fourth had only attended an outpatient clinic.
Conclusions: Community-onset, ESBL-producing and non-producing E. coli were diverse. Two ESBL-negative isolates were closely related to a local CTX-M-producing outbreak strain, suggesting gain or loss of a blaCTX-M-carrying plasmid. An outbreak strain was linked with prior hospital admission and appeared not to represent genuine community acquisition.
Keywords: cephalosporins , ESBLs , resistance , Enterobacteriaceae
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. A. Khan, N. Lemmens, E. Riera, T. Blonk, J. Goedhart, A. Van Belkum, W. Goessens, J. P. Hays, and M. Van Westreenen Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum {beta}-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay J. Antimicrob. Chemother., December 1, 2009; 64(6): 1330 - 1332. [Full Text] [PDF]
|
|
|
|
|
|
A. Tsakris, A. Ikonomidis, A. Poulou, N. Spanakis, S. Pournaras, and F. Markou Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-{beta}-lactamase J. Antimicrob. Chemother., July 1, 2007; 60(1): 136 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Tarrant, A. P. MacGowan, and T. R. Walsh Occurrence and current frequency of CTX-M-type {beta}-lactamases from a regional hospital in the South West of England J. Antimicrob. Chemother., April 1, 2007; 59(4): 815 - 816. [Full Text] [PDF]
|
|